Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A single stage phase II, multi-centre, open label study of Glivec in combination with pioglitazone, etoricoxib, dexamethasone and low-dose treosulfane for anti-inflammatory and angiostatic treatment in patients with hormone-refractory prostate cancer https://kusajili.fr:443/Trial/FSuOgC_XJE6FhoALxdBekQ%24a-single-stage-phase-ii-multi-centre-open-label-study-of-glivec-in-combination-with-pioglitazone-etoricoxib-dexamethasone-and-l
I have read and accept the terms of use of the site and the Privacy Policy
Send your message